HK2 and breast carcinoma: A study managed by Ni and colleagues revealed another phenomenon of chemoresistance in which circHIKP3 overexpression suppressed miR-1286 to enhance hexokinase 2 (HK2) expression and decreased the response to paclitaxel treatment in breast cancer cells [62].